Talks to replace Novo Nordisk CEO lasted several weeks, board chair says
COPENHAGEN, May 16 (Reuters) - Discussions between Novo Nordisk NOVOb.CO and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ongoing for the past few weeks, the company's board Chair Helge Lund told Reuters on Friday.
Meanwhile, outgoing Chief Executive Lars Fruergaard Jorgensen told Danish broadcaster TV2 that he was surprised by the decision, and that he had only been informed "very recently".
"I did not see this coming," Fruergaard Jorgensen told TV2.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

Micron Stock Forecast: Can the AI Memory Super-Cycle Drive MU to $3,000 by 2030?

Dell Stock Analysis: Is It Still Undervalued and the Best AI Infrastructure Play by 2026?

Meta Stock Price Forecast 2026-2030: Can META Hit $1,000?

Vanguard ETF Could Beat the S&P 500 Again in 2026 —— Why Investors Are Paying Attention

Tradingkey







